PERSPECTA

News from every angle

Back to headlines

CRISPR Therapeutics AG (CRSP) a Moderate Buy, Per Wall Street

7 Mar, 12:10 — 7 Mar, 12:10
PostShare

Sources

Showing 1 of 1 sources